Abstract
Background: Testosterone levels are differentially linked with diabetes risk in men and women: lower testosterone levels in men and higher testosterone levels in women are associated with type 2 diabetes, though, the mechanisms are not fully clear. We addressed sex-specific links between testosterone and major pathogenetic mechanisms of diabetes.Methods: We analyzed data of 623 subjects (202 male, 345 female without, and 76 female with oral contraceptive therapy [OCT]) for whom insulin sensitivity and insulin secretion were assessed by oral glucose tolerance test. Body fat percentage was assessed by bioelectrical impedance. Testosterone was measured by enzyme-linked immunoassay; free testosterone and Framingham risk score were calculated.Results: There were significant interactions between testosterone and sex for all tested metabolic traits. Increasing testosterone was associated with less body fat, elevated insulin sensitivity, and reduced glycemia, independent of adiposity in men. In women without OCT, testosterone correlated with more body fat, insulin resistance, and higher glucose concentrations. Testosterone was not associated with insulin secretion in either sex, but with lower Framingham risk score in men and higher Framingham risk score in women.Conclusions: Similar to diabetes risk, insulin resistance has different association directions with testosterone levels in males and females. Insulin resistance could therefore constitute the best biological candidate linking testosterone levels and diabetes prevalence. The question of antiandrogen therapy being able to improve metabolism, glucose tolerance and cardiovascular risk in women was not clarified in our study but should be reviewed with higher numbers in a carefully matched study to reduce the influence of confounding variables.
Highlights
Epidemiological studies observed a divergent association between testosterone levels and risk for type 2 diabetes in men and women: in men, lower testosterone levels are associated with elevated risk for type 2 diabetes
Besides inducing clinical signs of hyperandrogenemia, Polycystic ovary syndrome (PCOS) is strongly associated with diabetes risk [4]
We analyzed data of 421 female and 202 male subjects from the ongoing TUEF study (Tuebingen Family Study), that includes persons at elevated risk for type 2 diabetes [11], for whom both insulin sensitivity and insulin secretion were assessed during a frequent sampling 75 g oral glucose tolerance test
Summary
Epidemiological studies observed a divergent association between testosterone levels and risk for type 2 diabetes in men and women: in men, lower testosterone levels are associated with elevated risk for type 2 diabetes. Higher testosterone levels associate with increased diabetes risk in women [1]. Polycystic ovary syndrome (PCOS) is the condition that most often causes elevated testosterone concentration in women [3]. In men marked pharmacological lowering of circulating testosterone levels by androgen deprivation therapy, e.g., for the treatment of prostate cancer, increases diabetes risk [5]. Testosterone levels are differentially linked with diabetes risk in men and women: lower testosterone levels in men and higher testosterone levels in women are associated with type 2 diabetes, though, the mechanisms are not fully clear. We addressed sex-specific links between testosterone and major pathogenetic mechanisms of diabetes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.